Literature DB >> 15729725

Development of the vasculature in "pushing-type" liver metastases of an experimental colorectal cancer.

Sándor Paku1, László Kopper, Péter Nagy.   

Abstract

A mechanism for stroma formation (development of vasculature and supportive connective tissue) is suggested in an experimental "pushing-type" colorectal carcinoma liver metastasis model. The key element is the appearance of smooth muscle actin (SMA)-positive cells and the sinusoidal lakes at the border of the metastases. These lakes are the consequence of the disappearance ('stepping back' of hepatocytes from the border zone, resulting in the fusion of partially capillarized sinusoids. The growing tumor incorporates SMA-expressing cells and sinusoidal lakes. SMA-positive cells produce collagenous matrix, whereas the lakes become the central vessels within the connective tissue columns. Formation of these columns within the tumor is a consequence of the compression atrophy of the base of the incorporated liver tissue, leading to partial separation of the innermost part of the invagination containing functional vessel(s) from the surrounding liver. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15729725     DOI: 10.1002/ijc.20886

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

Review 1.  Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications.

Authors:  Balázs Döme; Mary J C Hendrix; Sándor Paku; József Tóvári; József Tímár
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Paracrine signalling in colorectal liver metastases involving tumor cell-derived PDGF-C and hepatic stellate cell-derived PAK-2.

Authors:  Obul R Bandapalli; Stephan Macher-Goeppinger; Peter Schirmacher; Karsten Brand
Journal:  Clin Exp Metastasis       Date:  2012-02-24       Impact factor: 5.150

3.  The histological growth pattern of colorectal cancer liver metastases has prognostic value.

Authors:  Gert G Van den Eynden; Nigel C Bird; Ali W Majeed; Steven Van Laere; Luc Y Dirix; Peter B Vermeulen
Journal:  Clin Exp Metastasis       Date:  2012-04-03       Impact factor: 5.150

Review 4.  Intussusceptive angiogenesis and its counterpart intussusceptive lymphangiogenesis.

Authors:  L Díaz-Flores; R Gutiérrez; S Gayoso; M P García; M González-Gómez; L Díaz-Flores; R Sánchez; J L Carrasco; J F Madrid
Journal:  Histol Histopathol       Date:  2020-04-24       Impact factor: 2.303

5.  A new mechanism for pillar formation during tumor-induced intussusceptive angiogenesis: inverse sprouting.

Authors:  Sándor Paku; Katalin Dezso; Edina Bugyik; József Tóvári; József Tímár; Péter Nagy; Viktoria Laszlo; Walter Klepetko; Balázs Döme
Journal:  Am J Pathol       Date:  2011-08-09       Impact factor: 4.307

6.  Antitumor effect of FP3 in a patient-derived tumor tissue xenograft model of gastric carcinoma through an antiangiogenic mechanism.

Authors:  Ketao Jin; Huanrong Lan; Feilin Cao; Zhenzhen Xu; Na Han; Guangliang Li; Kuifeng He; Lisong Teng
Journal:  Oncol Lett       Date:  2012-02-10       Impact factor: 2.967

Review 7.  Targeting cancer stem cells to modulate alternative vascularization mechanisms.

Authors:  Elena Monzani; Caterina Am La Porta
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

8.  Development of arterial blood supply in experimental liver metastases.

Authors:  Katalin Dezso; Edina Bugyik; Veronika Papp; Viktória László; Balázs Döme; József Tóvári; József Tímár; Péter Nagy; Sándor Paku
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

Review 9.  Targeting tumor metastases: Drug delivery mechanisms and technologies.

Authors:  Vidya Ganapathy; Prabhas V Moghe; Charles M Roth
Journal:  J Control Release       Date:  2015-09-25       Impact factor: 9.776

Review 10.  Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?

Authors:  Tom Donnem; Jiangting Hu; Mary Ferguson; Omanma Adighibe; Cameron Snell; Adrian L Harris; Kevin C Gatter; Francesco Pezzella
Journal:  Cancer Med       Date:  2013-07-08       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.